Repp Health Releases Next Generation Location Intelligence Solution for Healthcare Providers

BOULDER, Colo., May 21, 2019 /PRNewswire/ — Repp Health is pleased to announce the release of Repp Eo™, a next generation real time tracking solution developed specifically for the healthcare market.

Repp Eo provides precise X,Y coordinates similar to GPS. It’s much easier to deploy, a fraction of the cost than other tracking solutions and has a familiar map interface with a blue dot experience.

“It’s time for healthcare to synchronize and accelerate. Increasing the efficiency and utilization of assets and people will improve patient satisfaction and drive costs down.” David Sachs, CEO, and Co-Founder, Repp Health

Real time location intelligence on patients, assets and staff can help hospitals move patients through the care process more efficiently, visually augment the move toward hospital “command and control centers” and help healthcare organizations prepare for value-based reimbursement. Putting the right people in the right place at the right time ensures more efficient delivery of care.

To date, tracking in healthcare has been difficult to deploy, very expensive and lacking accuracy. Repp Eo ultra-wideband (UWB), proprietary technology combines a limited on-premise footprint with secure cloud-based data processing to create a level of accuracy previously unavailable to indoor tracking solutions.

About Repp Health

Repp Health was founded in 2018 by Michael Sachs, who’s prior businesses have included: Sachs Group, now part of IBM Watson, Aetna’s BSwift & SG2/Vizient. Mr. Sachs is a healthcare visionary who has brought his immense insights into optimizing the patient care process.

Contact

Repp Health
Heather Swanson, 720.272.8755
hswanson@repphealth.io

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/repp-health-releases-next-generation-location-intelligence-solution-for-healthcare-providers-300854077.html

SOURCE Repp Health

Staff

Recent Posts

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

3 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

3 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

3 hours ago

RazorMetrics Drives More Than $11 Million in Prescription Drug Savings for Ohio Plans and Residents

AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy cost containment…

3 hours ago

NYSE Content Advisory: Pre-Market Update + Cast of HBO’s ‘Industry’ Rang Thursday’s Closing Bell

NEW YORK, Jan. 30, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…

3 hours ago

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

HENDERSON, Nev., Jan. 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national…

3 hours ago